xAnts

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

Paul J. Diaz, President and CEO of Myriad, adds "PATHOMIQ's technology platform, together with Myriad's infrastructure and commercial capabilities allows for an accelerated pace of innovation to bring advanced diagnostic products to market that are c ...Read more